(GJAN) Exchange-Traded Fund VIII - Overview

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US33740F5162

Etf: SPDR, S&P, 500, ETF

Total Rating 39
Risk 62
Buy Signal 0.62
Risk 5d forecast
Volatility 6.94%
Relative Tail Risk 0.36%
Reward TTM
Sharpe Ratio 0.61
Alpha 0.42
Character TTM
Beta 0.511
Beta Downside 0.549
Drawdowns 3y
Max DD 10.60%
CAGR/Max DD 1.13

Description: GJAN Exchange-Traded Fund VIII December 29, 2025

First Trust FT Cboe Vest U.S. Equity Moderate Buffer ETF (ticker GJAN) seeks to achieve its objective by allocating virtually all of its capital to Flexible Exchange® Options that track the price performance of the SPDR S&P 500 ETF (SPY), which itself replicates the S&P 500 Index through direct stock holdings.

Because the strategy relies on a single underlying index, the fund is classified as “non-diversified” under SEC rules, meaning it holds a concentrated exposure to the broad U.S. equity market rather than a wide array of asset classes.

Key quantitative points (as of Q3 2024): the fund’s expense ratio is 0.30%; it offers a 15% downside buffer with a 15% upside participation limit for the calendar year; and its implied volatility, derived from the underlying options, sits around 12% annualized, roughly in line with the S&P 500’s historical volatility.

Macro-level drivers that will materially affect GJAN’s performance include the Federal Reserve’s interest-rate policy (higher rates tend to compress equity valuations), U.S. GDP growth trends (which influence corporate earnings), and sector-specific earnings momentum-particularly in information technology and consumer discretionary, which together comprise roughly 30% of the S&P 500 weightings.

For a deeper quantitative breakdown of GJAN’s risk-return profile, you might explore the ValueRay platform.

What is the price of GJAN shares?

As of February 05, 2026, the stock is trading at USD 42.94 with a total of 71,286 shares traded.
Over the past week, the price has changed by -0.58%, over one month by +0.07%, over three months by +2.46% and over the past year by +10.19%.

Is GJAN a buy, sell or hold?

Exchange-Traded Fund VIII has no consensus analysts rating.

What are the forecasts/targets for the GJAN price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 46.2 7.6%

GJAN Fundamental Data Overview February 02, 2026

Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 432.7m USD (432.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 432.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 432.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.80% (E(432.7m)/V(432.7m) * Re(7.80%) + (debt-free company))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for GJAN ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle